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Abstract
Background: The synaptic and cellular mechanisms of pain-related central sensitization in the
spinal cord are not fully understood yet. Calcitonin gene-related peptide (CGRP) has been
identified as an important molecule in spinal nociceptive processing and ensuing behavioral
responses, but its contribution to synaptic plasticity, cellular mechanisms and site of action in the
spinal cord remain to be determined. Here we address the role of CGRP in synaptic plasticity in
the spinal dorsal horn in a model of arthritic pain.
Results: Whole-cell current- and voltage-clamp recordings were made from substantia gelatinosa
(SG) neurons in spinal cord slices from control rats and arthritic rats (> 6 h postinjection of kaolin/
carrageenan into the knee). Monosynaptic excitatory postsynaptic currents (EPSCs) were evoked
by electrical stimulation of afferents in the dorsal root near the dorsal root entry zone. Neurons
in slices from arthritic rats showed increased synaptic transmission and excitability compared to
controls. A selective CGRP1 receptor antagonist (CGRP8-37) reversed synaptic plasticity in
neurons from arthritic rats but had no significant effect on normal transmission. CGRP facilitated
synaptic transmission in the arthritis pain model more strongly than under normal conditions
where both facilitatory and inhibitory effects were observed. CGRP also increased neuronal
excitability. Miniature EPSC analysis suggested a post- rather than pre-synaptic mechanism of
CGRP action.
Conclusion: This study is the first to show synaptic plasticity in the spinal dorsal horn in a model
of arthritic pain that involves a postsynaptic action of CGRP on SG neurons.
Background
Inflammatory processes in peripheral tissues lead to cen-
tral sensitization in the spinal cord, which contributes to
hyperalgesia and allodynia typically associated with
inflammatory pain. Although evidence suggests that plas-
tic changes in the spinal dorsal horn account for central
sensitization, the relative contribution of pre- and postsy-
naptic mechanisms and of peripheral and supraspinal fac-
tors are not entirely clear. The superficial dorsal horn of
the spinal cord, particularly substantia gelatinosa (SG), is
a major projection site of small-diameter afferent nerve
fibers that predominantly transmit nociceptive signals
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[1,2]. SG neurons also receive descending inputs from the
brainstem [1,3]. Therefore, in addition to intraspinal neu-
roplastic changes, peripheral as well as supraspinal factors
may contribute to central sensitization.
Pain-related neuroplastic changes in central nervous sys-
tem (CNS) structures can be shown definitively by the
electrophysiological analysis of synaptic transmission and
neuronal excitability in spinal cord or brain slice prepara-
tions obtained from animals in which an experimental
pain state has been induced [4-7]. The slice preparation
allows the analysis of pain-related plasticity because it is
disconnected from the site of peripheral injury (inflam-
mation) and from other CNS areas, be it supraspinal sites
(spinal cord slice) or spinal cord (brain slices). Therefore,
changes measured in the slice preparation are maintained
independently of continuous inputs to the area of interest.
Accordingly, changes of synaptic circuitry in SG neurons
were shown in slices from animals with complete Fre-
und's adjuvant induced hindpaw inflammation [4,5,8,9]
and synaptic plasticity was demonstrated in amygdala
neurons from animals with knee joint arthritis [7,10,11].
The kaolin and carrageenan (K/C) induced knee joint
arthritis is a well established model of inflammatory pain.
Electrophysiological, pharmacological, neurochemical
and behavioral studies have used this model to analyze
pain mechanisms at different levels of the nervous system
and showed the sensitization of primary afferent nerve
fibers, spinal dorsal horn neurons and neurons in the cen-
tral nucleus of the amygdala (CeA) [12-17]. Using slice
preparations, synaptic plasticity was demonstrated in the
CeA, but not yet in the spinal cord, in the K/C arthritis
pain model.
The purpose of this study was to compare synaptic trans-
mission and neuronal excitability in SG neurons in spinal
cord slices from normal and from arthritic animals using
patch-clamp recordings. Another goal was to determine
the role of calcitonin gene-related peptide (CGRP) in
pain-related spinal plasticity since CGRP has emerged as
an important molecule at different levels of the pain neu-
raxis in the arthritis pain model.
CGRP is a 37 amino acid peptide that activates adenylyl
cyclase and protein kinase A through G-protein-coupled
receptors, including the CGRP1 receptor for which selec-
tive antagonists are available [18-21]. CGRP is involved in
peripheral and spinal pain mechanisms [22-29]. We
showed recently that CGRP also plays an important role
in the transmission of nociceptive information to the
amygdala through the spino-parabrachio-amygdaloid
pathway [10].
The source of CGRP in the spinal cord dorsal horn is pri-
mary afferents. CGRP coexists with substance P in small-
diameter afferent fibers, and CGRP containing terminals
and CGRP receptors are found in the dorsal horn, includ-
ing SG [30-33]. CGRP is released in the spinal dorsal horn
by noxious stimulation and peripheral inflammation
such as the K/C arthritis [26,34,35]. Peripheral inflamma-
tion also leads to changes in CGRP binding sites in the
dorsal horn [32,36].
Spinal application of CGRP facilitates nociceptive behav-
ior [24,37,38] and sensitizes the responses of dorsal horn
neurons to innocuous and noxious peripheral stimula-
tion [28,29,38,39] and to intraspinally administered exci-
tatory amino acids [23] and substance P [39]. In a slice
preparation, CGRP produced a slow depolarization and
enhanced excitability of dorsal horn neurons; the effect on
evoked synaptic transmission was not studied [40]. Con-
versely, block of spinal CGRP receptors with an antagonist
(CGRP8-37) or antiserum induced antinociception in ani-
mal models of inflammatory [25,41,42,42-44] or central
neuropathic pain [45]. CGRP8-37 also inhibited the
responses of spinal dorsal horn neurons to transdermial
electrical stimulation of the hindpaw [46] and to noxious
mechanical stimulation of the knee joint [29]. CGRP8-37
prevented or reversed central sensitization of dorsal horn
neurons in the arthritis and capsaicin pain models
[28,29]. Arthritic CGRP knockout mice showed reduced
nociceptive behavioral responses [47].
Although it is widely accepted that CGRP plays an impor-
tant role in the modulation of spinal nociceptive process-
ing, the cellular mechanisms and pre- or post-synaptic
sites of action through which CGRP contributes to central
sensitization remain to be determined. The present study
addressed the role of CGRP in synaptic plasticity in the
superficial dorsal horn in vitro in a model of arthritic pain
induced in vivo. Our data show for the first time synaptic
plasticity and increased excitability of SG neurons in the
K/C arthritis pain model. A CGRP receptor antagonist
inhibits synaptic plasticity whereas CGRP itself facilitates
synaptic transmission through a postsynaptic mechanism
that involves direct membrane effects on SG neurons.
Results
Whole-cell patch-clamp recordings of SG neurons were
made in spinal cord slices from normal naïve rats (n = 31
neurons) and rats with a knee joint arthritis induced 6 h
before slices were obtained (n = 25 neurons). The record-
ing sites were always visually verified to be in the central
part of the gray translucent region forming lamina II. All
SG neurons in this study showed monosynaptic responses
(excitatory postsynaptic currents, EPSCs) to electrical
stimulation of afferent fibers in the dorsal root (DR) near
the dorsal root entry zone (DREZ). EPSCs were judged toMolecular Pain 2006, 2:31 http://www.molecularpain.com/content/2/1/31
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be monosynaptic on the basis of stable latencies of the
EPSC peak amplitude (coefficient of variation < 2%,
[48,49]). Calculated from latency and distance between
stimulation and recording sites, the conduction velocities
(CV) ranged from 0.15 to 0.85 m/s (mean 0.46 ± 0.03 m/
s), which is in the range of rodent C-fibers [48,49]. No dif-
ference in resting transmembrane potential (RMP) and
input resistance (Ri) was detected between neurons from
normal rats (RMP = -58.7 ± 1.7 mV; Ri = 211.8 ± 16.6 MΩ)
and from arthritic rats (RMP = -57.0 ± 1.8 mV; Ri = 205.3
± 13.7 MΩ).
Synaptic plasticity in SG neurons in the arthritis pain 
model
Input-output functions of monosynaptic inputs to SG
neurons increased in the arthritis pain model (Figure 1).
Monosynaptic EPSCs with progressively larger amplitudes
were evoked by electrical DR/DREZ stimulation with
increasing intensities. Compared with control SG neurons
from normal animals, synaptic transmission was signifi-
cantly enhanced in SG neurons recorded in slices from
arthritic rats. Input-output relationships were obtained by
measuring EPSC peak amplitude (pA) as a function of
afferent fiber stimulus intensity (μA) for each neuron (see
individual examples of an SG neuron in a slice from a nor-
mal animal [Fig. 1A] and in an SG neuron from an
arthritic animal [Fig. 1B]). In arthritis, evoked monosyn-
aptic EPSCs had larger amplitudes, but EPSC threshold
was unchanged. The input-output relationships of SG
neurons from control rats (n = 16) and SG neurons from
arthritic rats (n = 9) were significantly different (Fig. 1C; P
< 0.0001, F 1,207 = 58.45, two-way ANOVA). These data
show enhanced synaptic transmission at first-order syn-
apses on SG neurons in the arthritis pain model.
Enhanced synaptic transmission in the reduced slice prep-
aration indicates synaptic plasticity because the arthritis
pain-related changes are maintained, at least in part, inde-
pendently of peripheral and supraspinal mechanisms.
Increased excitability of SG neurons in the arthritis pain 
model
Compared with control neurons, neurons from arthritic
rats had a lower threshold and higher rate of action poten-
tial firing generated by direct depolarization of the cell via
the recording electrode in current-clamp mode (Figure 2).
Input-output functions of neuronal excitability were
obtained by measuring the number of action potentials
(Hz) evoked by depolarizing current pulses of increasing
magnitude (0 to 200 pA; see individual examples in Fig.
2A and 2B). Input-output functions of SG neurons from
arthritic animals (n = 13) were significantly increased
compared to control neurons from normal animals (n =
25; Fig. 2C; P < 0.001; F 1,180 = 12.77, two-way ANOVA).
The threshold for evoking action potentials was lower in
SG neurons from arthritic animals (n = 11) than in con-
trol neurons (n = 17), i.e., action potential firing occurred
at more hyperpolarized membrane potentials (Fig. 2D; P
< 0.01, unpaired t-test).
Inhibition of pain-related synaptic plasticity by a CGRP1 
receptor antagonist (CGRP8-37)
CGRP8-37 (1 μM; 10 min) inhibited synaptic transmis-
sion in SG neurons in slices from arthritic animals but had
Synaptic transmission in SG neurons is enhanced in the  arthritis pain model Figure 1
Synaptic transmission in SG neurons is enhanced in 
the arthritis pain model. A,B, Whole-cell voltage-clamp 
recordings of monosynaptic EPSCs evoked with increasing 
stimulus intensities in an SG neuron in a spinal cord slice 
from a normal animal and in an SG neuron in a slice from an 
arthritic animal (obtained 6 h post-induction of arthritis). 
Evoked monosynaptic EPSCs had larger amplitudes in arthri-
tis than under control conditions. Square wave electrical 
stimuli of 150 μs duration were delivered at a frequency < 
0.25 Hz. Stimulus intensity was increased from 0–800 μA. 
Each trace is the average of 3–4 EPSCs. Neurons were held 
at -60 mV. C, Input-output relationships of monosynaptic 
EPSC peak amplitudes (pA) evoked in SG neurons from nor-
mal rats (n = 16) and from arthritic rats (n = 9) were signifi-
cantly different. * P < 0.05, ** P < 0.01 (two-way ANOVA 
followed by Bonferroni posttests). Data are given as the 
means ± SEM.Molecular Pain 2006, 2:31 http://www.molecularpain.com/content/2/1/31
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no significant effect on normal synaptic transmission
(Figure 3). Individual examples show that CGRP8-37
clearly inhibited monosynaptic EPSCs recorded in an SG
neuron in a slice from an arthritic rat (Fig. 3B) but had lit-
tle effect in an SG neuron in a slice from a normal rat (Fig.
3A). In the sample of SG neurons from arthritic rats (n =
5), CGRP8-37 inhibited synaptic strength (measured as
peak amplitudes, Fig. 3C) and total charge (measured as
area under the curve, Fig. 3D) significantly (P < 0.01,
paired t-test), but had no significant effect on synaptic
transmission in SG neurons from normal rats (n = 7).
These data suggest that CGRP1 receptors are endog-
enously activated to facilitate synaptic transmission in the
arthritic pain model. Next, we determined the effect and
site of action of the receptor ligand CGRP.
Synaptic facilitation by CGRP is enhanced in the arthritis 
pain model
CGRP enhanced synaptic transmission in a concentra-
tion-dependent fashion (Figure 4). Individual examples
show that CGRP (10 nM; 10 min) increased monosynap-
tic EPSCs in an SG neuron from an arthritic rat (Fig. 4B)
more strongly than in an SG neuron from a normal rat
(Fig. 4A). Concentration-response data (Fig. 4C) show
that the maximum facilitatory effect (efficacy) of CGRP
was significantly (P < 0.01, F 1,26 = 9.58, two-way ANOVA)
greater in SG neurons from arthritic rats (n = 16) com-
pared to control neurons from normal animals (n = 10).
The potency of CGRP was comparable under normal con-
ditions (EC50 = 2.0 nM) and in arthritis (EC50 = 1.4 nM).
It should be noted that CGRP attenuated synaptic trans-
mission in 6 of 16 SG neurons from normal animals but
not in any SG neuron from arthritic animals.
Postsynaptic effects of CGRP
To determine the site of action of CGRP we used well-
established electrophysiological methods, including the
analysis of miniature EPSCs (mEPSCs) (Figure 5) and
neuronal excitability (Figure 6). Presynaptic changes at
the transmitter release site affect mEPSC frequency,
whereas changes at the postsynaptic membrane alter
mEPSC amplitude (quantal size) [50,51]. CGRP (10 nM;
10 min) increased the amplitude of mEPSCs in TTX (1
μM)-containing ACSF without affecting their frequency,
suggesting a post- rather than pre-synaptic site of action
(Figure 5). This postsynaptic effect is illustrated in the cur-
rent traces recorded in voltage-clamp mode in an individ-
ual SG neuron (Fig. 5A). Normalized cumulative
distribution analysis of mEPSC amplitude and frequency
shows that CGRP caused a significant shift toward higher
amplitude in this neuron (see Fig. 5B and 5C) and also
increased mean mEPSC amplitude in the sample of neu-
rons (Fig. 5B, inset; P < 0.05, paired t-test, n = 5) but had
no effect on the interevent interval (frequency) distribu-
tion (Fig. 5C, inset).
CGRP increased neuronal excitability (Figure 6). Action
potentials were evoked in current-clamp mode by direct
depolarizing current injections (500 ms) of increasing
magnitude (0 to 250 pA) through the patch electrode (Fig.
6A and 6B). Input-output functions of neuronal excitabil-
ity were obtained by averaging the frequency of action
potentials (spikes) evoked at each current intensity (Fig.
6C). CGRP (10 nM; 10 min) increased the input-output
function significantly (n = 5; P < 0.001; F 1,180 = 12.77,
two-way ANOVA) while lowering the threshold for action
potential generation to more hyperpolarized membrane
potentials (Fig. 6D; P < 0.01, paired t-test). In the presence
of TTX (1 μM) CGRP (10 nM) also induced an inward
membrane current that was significantly larger (P < 0.01,
unpaired t-test) in SG neurons from arthritic rats (27.3 ±
Increased excitability of SG neurons in the arthritis pain  model Figure 2
Increased excitability of SG neurons in the arthritis 
pain model. Increased action potential firing rates and 
decreased thresholds for action potentials were recorded in 
SG neurons in slices from arthritic rats compared to con-
trols. A, B, Current-clamp recordings of action potentials 
(spikes) generated by direct intracellular injections of depo-
larizing current pulses of increasing magnitude (0 to 200 pA; 
500 ms) in an SG neuron from a normal animal (A) and in an 
SG neuron from an arthritic animal (B). C, Analysis of the 
input-output relationships shows significantly increased spike 
frequency in arthritis (n = 13 neurons) compared to control 
(n = 25 neurons; P < 0.05; two-way ANOVA followed by 
Bonferroni posttests). D, Significantly decreased spike 
thresholds (membrane potentials at which action potential 
firing started) were recorded in SG neurons in arthritis (n = 
11) compared to control neurons (n = 17; P < 0.01; unpaired 
t-test). * P < 0.05, ** P < 0.01.Molecular Pain 2006, 2:31 http://www.molecularpain.com/content/2/1/31
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CGRP8-37 inhibits pain-related synaptic plasticity but has no significant effect on normal synaptic transmission Figure 3
CGRP8-37 inhibits pain-related synaptic plasticity but has no significant effect on normal synaptic transmis-
sion. A, B, CGRP8-37 (1 μM) inhibited monosynaptic EPSCs recorded in an SG neuron in a slice from an arthritic rat (B) but 
not in another SG neuron in a slice from a normal rat (A). Each trace is the average of 8–10 monosynaptic EPSCs. C, D, 
CGRP8-37 (1 μM) significantly inhibited the EPSC peak amplitude (C), a measure of synaptic strength, and area under the curve 
(total charge, D) in SG neurons in slices from arthritic rats (P < 0.01, paired t-test, n = 5) but not in control neurons (n = 7) 
from normal rats. Analysis of raw data (pA, pC) is shown on the left; normalized data (% of predrug values) are shown on the 
right in C and D. Voltage-clamp recordings were made at -60 mV. CGRP8-37 was applied by superfusion of the slice in ACSF 
for 10–12 min. ** P < 0.01 (paired t-test).Molecular Pain 2006, 2:31 http://www.molecularpain.com/content/2/1/31
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3.1 pA, n = 5) than in SG neurons from normal rats (12.4
± 2.9 pA, n = 5). These data suggest a direct postsynaptic
effect on membrane properties.
Discussion
The key findings of this study are as follows. Synaptic
transmission and neuronal excitability in SG neurons are
increased in slices from arthritic rats compared to control
Miniature EPSC (mEPSC) analysis indicates post- rather than  pre-synaptic effects of CGRP Figure 5
Miniature EPSC (mEPSC) analysis indicates post- 
rather than pre-synaptic effects of CGRP. A, Original 
current traces of mEPSC recorded in an individual SG neu-
ron in the presence of TTX (1 μM) show that CGRP (10 nM; 
10 min) increases amplitude but not frequency of mEPSCs. 
B, C: Normalized cumulative distribution analysis of mEPSC 
amplitude and frequency in the same neuron as in 5A shows 
that CGRP caused a significant shift toward higher amplitude 
(B, P < 0.001, Kolmogorov-Smirnov test) but had no effect 
on the interevent interval (frequency) distribution (C). In the 
sample of neurons (n = 5) CGRP selectively increased mean 
mEPSC amplitude (P < 0.05, paired t-test) but not mEPSC 
frequency (see bar histograms in B, C). Symbols and error 
bars represent mean ± SEM. Neurons were recorded in volt-
age-clamp at -60 mV. * P < 0.05.
Enhanced synaptic facilitation by CGRP in the arthritis pain  model Figure 4
Enhanced synaptic facilitation by CGRP in the arthri-
tis pain model. A, B, Whole-cell voltage-clamp recordings 
of monosynaptic EPSCs in an SG neuron in a slice from a 
normal animal (A) and in another SG neuron in a slice from 
an arthritic animal (B, 6 h postinduction of arthritis). CGRP 
(10 nM) potentiated synaptic transmission more strongly in 
arthritis than under normal conditions. Square wave electri-
cal stimuli of 150 μs duration were delivered at a frequency < 
0.25 Hz. Each trace is the average of 8–10 EPSCs. C, Con-
centration-response data show that the maximum effect (effi-
cacy) of CGRP was significantly greater in SG neurons from 
arthritic rats (n = 16) compared to control neurons from 
normal animals (n = 10). Peak EPSC amplitudes during each 
concentration of CGRP were averaged and expressed as per-
cent of predrug (baseline) control (100%). Sigmoid curves 
were fitted to the data using the following formula for nonlin-
ear regression (GraphPad Prism 3.0; Y = A+(B-A)/[1+(10C/
10X)D], where A = bottom plateau, B = top plateau, C = 
log(EC50), D = slope coefficient. Symbols show mean ± SEM. 
Neurons were held at -60 mV. CGRP was applied by super-
fusion of the slice in ACSF for 10 min. * P < 0.05 (two-way 
ANOVA followed by Bonferroni posttests).Molecular Pain 2006, 2:31 http://www.molecularpain.com/content/2/1/31
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neurons from normal rats. These data suggest plastic
changes in the arthritis pain model that are maintained in
the reduced slice preparation independently of peripheral
and supraspinal influences. Blockade of CGRP receptors
inhibits synaptic plasticity in SG neurons from arthritic
animals, suggesting the contribution of endogenously
CGRP increases neuronal excitability and induces direct membrane currents Figure 6
CGRP increases neuronal excitability and induces direct membrane currents. A, B, Current-clamp recordings of 
action potentials (spikes) generated in an SG neuron by direct intracellular injections of depolarizing current pulses of increas-
ing magnitude (0 to 250 pA; 500 ms) before (A) and during CGRP (10 nM, B). C, CGRP increased input-output function by sig-
nificantly increasing spike frequency (n = 5 neurons; P < 0.05–0.01, two-way ANOVA followed by Bonferroni posttests). For 
the measurement of action potential firing in current-clamp, neurons were recorded at -60 mV. D, CGRP (10 nM) also 
decreased spike thresholds (membrane potentials at which action potential firing started) significantly (n = 5; P < 0.01, paired t-
test). * P < 0.05, ** P < 0.01.Molecular Pain 2006, 2:31 http://www.molecularpain.com/content/2/1/31
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activated CGRP receptors. CGRP facilitates synaptic trans-
mission and increases neuronal excitability through a
postsynaptic site of action.
This study focused on synaptic transmission of afferent
information to SG neurons. According to conventional
criteria such as stable latencies of the EPSC peak [48,49],
synaptic responses were considered monosynaptic and
had a latency that indicated a slow conduction velocity
(CV) of the responsible afferents in the range of rodent C-
fibers [48,49,52]. However, a note of caution should be
added. Since we were not able to preserve long dorsal
roots in the majority of the experiments but rather stimu-
lated the DR stump near the DREZ, we can not be sure that
the calculated CV at the central terminal accurately reflects
the CV in the axon of the peripheral fiber. Still, it is evi-
dent that afferent input to SG neurons from small diame-
ter fibers but not fast conducting A-beta fibers was studied
here. Further, the SG neurons included in this study ful-
filled the criteria for central SG neurons with monosynap-
tic C-fiber input as described in detail by others [48,49].
Our data show for the first time changes of synaptic trans-
mission in small diameter fibers to SG neurons in a model
of arthritic pain. Previously, the slice preparation had
been used to determine changes in transmission to SC
neurons in an inflammatory pain model induced by intra-
plantar complete Freund's adjuvant 48 h or 7–10 d before
slices were obtained [4,5,9]. In these studies, changes in
synaptic transmission had been observed. They included
a lower threshold for evoking EPSCs in SG neurons, a rel-
ative increase in the C-fiber versus A-delta fiber evoked
EPSC amplitude, and an increased percentage of SG neu-
rons receiving mono- or polysynaptic A-beta input [4,5,9].
The present study extends these observations in several
ways. We used a different pain model, the K/C induced
arthritis that produces electrophysiological and behavio-
ral changes in vivo with a well defined and highly repro-
ducible time course [10,11,16,17]. This allowed us to
select a constant time point (6 h postinduction of arthri-
tis) to study changes in the slice preparation. Arthritis
pain-related changes reach a plateau 6 h postinduction
and persist at that level for days. Another novel aspect of
our studies is the analysis of complete input-output func-
tions of the DR-SG synapse and of neuronal excitability of
SG neurons. Our data show synaptic plasticity combined
with excitability changes in the arthritis pain model. There
was no significant change of the threshold for evoking
EPSCs suggesting that the stimulation and recording con-
ditions were indeed comparable in slices from normal
and arthritic animals. The fact that differences of synaptic
transmission between normal and arthritic conditions
were observed at different stimulus intensities along the
input-output relationships further suggests functional
changes rather than variability of the experimental condi-
tions.
The present study also offers a mechanism for these plastic
changes: enhanced function of CGRP1 receptors. A widely
used selective CGRP1 receptor antagonist (CGRP8-37)
[18,20,21] inhibited synaptic plasticity but had little effect
on normal transmission. These findings are consistent
with in vivo data showing that blockade of spinal CGRP
receptors inhibits sensitization of dorsal horn neurons in
pain models [28,29] and nociceptive behavior
[25,25,41,42,42-45] in pain models. Here we show for the
first time that the DR-SG circuitry is one site of action of
CGRP receptors to modulate synaptic transmission. CGRP
containing terminals and CGRP receptors are present in
the dorsal horn, including SG [30-33]. CGRP is released in
the dorsal horn in the K/C arthritis model [34].
Our data with exogenously administered CGRP further
indicate a post- rather than pre-synaptic site of action at
the DR-SG synapse and a direct membrane effect on SG
neurons. This mechanism of action could explain the
CGRP-induced sensitization of dorsal horn neurons in
vivo [23,28,29,38,39,39] and facilitation of nociceptive
behavior [24,37,38]. CGRP has been shown before to
depolarize and increase excitability of dorsal horn neu-
rons in current-clamp [40]. Our simultaneous recording
and analysis of evoked synaptic transmission, miniature
EPSCs and membrane currents in voltage-clamp and
excitability in current-clamp show a direct facilitatory
action of CGRP on SG neurons to increase their respon-
siveness to afferent input and their output (action poten-
tial generation). The enhanced CGRP function in the
arthritis pain model could involve a change in the cou-
pling to downstream effector systems such as kinases and
ion channels as well as increased receptor expression or
affinity. The effects of peripheral inflammation on CGRP
binding sites in the dorsal horn have been reported to be
somewhat inconsistent in that a mixture of up- and down-
regulation was found [32,36]. The inhibitory effect of
CGRP on normal synaptic transmission observed in some
neurons could reflect an action on the recently described
inhibitory projection islet cells on central SG neurons
[48].
SG neurons with C-fiber input (such as those selected in
the present study) have been shown to excite monosynap-
tically SG neurons with A-delta input. These neurons then
excite monosynaptically lamina I neurons [49], some of
which project rostrally to form the spino-parabrachio-
amygdaloid pathway [49,53,54]. This pathway is highly
peptidergic and utilizes CGRP to transmit information to
the amygdala [10]Molecular Pain 2006, 2:31 http://www.molecularpain.com/content/2/1/31
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Conclusion
This study is the first to show synaptic plasticity in the spi-
nal dorsal horn (SG) in a model of arthritic pain. Synaptic
plasticity involves CGRP1 receptor activation. CGRP acts
postsynaptically to increase the input and output func-
tions of SG neurons.
Methods
Male Sprague Dawley rats (16–21 d) were housed in a
temperature controlled room and maintained on a 12 h
day/night cycle. Water and food were available ad libitum.
Electrophysiological data were obtained from untreated
normal rats and rats with monoarthritis in the knee (6 h
after induction). All experimental procedures were
approved by the Institutional Animal Care and Use Com-
mittee (IACUC) at the University of Texas Medical Branch
(UTMB) and conform to the guidelines of the Interna-
tional Association for the Study of Pain (IASP) and of the
National Institutes of Health (NIH).
Arthritis pain model
In the group of arthritic rats, arthritis was induced in the
left knee joint as previously described [7,10,11]. A kaolin
suspension (4%, 100 μl) was injected into the left knee
joint cavity through the patellar ligament. After repetitive
flexions and extensions of the knee for 15 minutes, a car-
rageenan solution (2%, 100 μl) was injected into the knee
joint cavity, and the leg was flexed and extended for
another 5 minutes. Spinal cord slices were obtained 6 h
after arthritis induction.
Spinal cord slice preparation
Transverse spinal cord slices were prepared using a modi-
fied version of the technique established by E.R. Perl's
group [48,49]. Rats were deeply anesthetized with pento-
barbital (50 mg/kg, i.p.). After a lumbosacral laminec-
tomy the spinal cord with associated dorsal roots on one
side was quickly removed and placed in ice-cold, sucrose-
substituted, artificial cerebrospinal fluid (sucrose ACSF)
containing (in mM): sucrose (234), KCl (3.6), CaCl2
(2.5), MgCl2 (1.2), NaH2PO5 (1.2), NaHCO3 (25), and
glucose (12); equilibrated to pH 7.4 with a mixture of
95% O2 and 5% CO2. A vibrotome (Camden Instruments,
London, UK) was used to prepare transverse (500 μm
thick) slices from the lumbar spinal cord. Spinal cord
slices were maintained at room temperature (21°C) for at
least 1 h in standard ACSF containing (in mM): NaCl
(117), KCl (4.7), NaH2PO4 (1.2), CaCl2  (2.5), MgCl2
(1.2), NaHCO3 (25), glucose (11); equilibrated to pH 7.4
with 95% O2 /5% CO2. A single slice was then transferred
to the recording chamber and submerged in ACSF, which
superfused the slice at ~5 ml/min.
Electrophysiology
Whole-cell current- and voltage-clamp recordings were
made from substantia gelatinosa (SG) neurons in trans-
verse lumbar spinal cord slices (500 μm) from normal rats
(controls) and arthritic rats (16–21 day old), using DIC-
enhanced infrared video-microscopy for visualization or
the "blind" patch technique as in our previous studies
[7,10,11]. Patch electrodes were made from borosilicate
glass capillaries (1.5 mm outer diameter, 1.12 mm inner
diameter; Drummond, Broomall, PA) pulled on a Flam-
ing-Brown micropipette puller (P-80/PC; Sutter Instru-
ments, Novato, CA). Patch electrodes had tip resistances
of 4–6 MΩ. The following internal solution was used
(compounds in mM): K-Gluconate (122), NaCl (5),
CaCl2 (0.3), EGTA (1), HEPES (10), Na2ATP (5), Na3GTP
(0.4), and MgCl2(2); pH 7.3; 300 mOsm.
Recording electrodes were positioned in the center of the
SG under visual control. The boundaries of the SG are eas-
ily discerned under light microscopy. After tight (> 1 GΩ)
seals were formed and the whole-cell configuration was
obtained, neurons were included in the sample if the rest-
ing membrane potential was more negative than -50 mV
and action potentials overshooting 0 mV were evoked by
direct depolarizing current injection through the record-
ing electrode. Data acquisition and analysis of voltage and
current signals were done using a dual 4-pole Bessel filter
(Warner Instrument Corp., Hamden, CT), low-noise Dig-
idata 1322 interface (Axon Instruments, Foster City, CA),
Axoclamp-2B or Axopatch 200 B amplifiers (Axon Instr.),
Pentium PC, and pCLAMP8 and pCLAMP9 software
(Axon Inst.). Recordings were made at -60 mV. Series
resistance was at least one order of magnitude less than
input resistance and was continuously monitored
throughout the experiment.
Monosynaptic excitatory postsynaptic currents (EPSCs)
were evoked by stimulation of the DR with a suction elec-
trode or, in the majority of experiments, by focal stimula-
tion of the DR stump near the DREZ with a concentric
bipolar electrode. Electrical stimuli (150 μs square-wave
pulses) were delivered at frequencies below 0.25 Hz.
Input-output relationships were obtained by increasing
the stimulus intensity in 50 or 100 μA steps. For the eval-
uation of a drug effect on synaptically evoked responses,
the stimulus intensity was adjusted to 80% of the intensity
required for orthodromic spike generation. EPSCs were
judged to be monosynaptic on the basis of stable latencies
of the EPSC peak amplitude (coefficient of variation < 2%
[48,49]). CV was estimated from latency of the evoked
EPSC peak and the conduction distance between stimula-
tion and recording sites.
The following parameters were recorded to measure
arthritis-related or drug-induced changes. Peak amplitudeMolecular Pain 2006, 2:31 http://www.molecularpain.com/content/2/1/31
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and area under the curve (AUC) of monosynaptic EPSCs
(typically the mean of 8–10 consecutive EPSCs) were
measured in voltage-clamp to determine synaptic strength
and total charge, respectively. Frequency and amplitude of
miniature EPSCs (mEPSCs, recorded in 1 μM TTX) were
determined from 1 min recording periods (voltage-
clamp) using the Mini Analysis Program 6.0.3 (Synap-
tosoft Inc., Decatur, GA). Input-out functions of excitabil-
ity were calculated from the number of evoked action
potentials (spikes) evoked by direct intracellular injec-
tions of depolarizing currents (500 ms; increments of 50
pA).
Drugs
CGRP (receptor agonist) and CGRP8-37 (selective CGRP1
receptor antagonist) [18,20,21] were dissolved in ACSF
on the day of the experiment and applied to the spinal
cord slice by gravity-driven superfusion in the ACSF for 10
min at a rate of 5 ml/min. Solution flow into the recording
chamber (1 ml volume) was controlled with a three-way
stopcock. Duration of drug application and concentra-
tions were selected based on our previous studies [10].
Data analysis and statistics
All averaged values are given as the mean ± SEM. Statisti-
cal significance was accepted at the level of P < 0.05.
Input-output functions and concentration-response rela-
tionships were compared using a two-way ANOVA with
Bonferroni posttests. EC50 values were calculated from sig-
moid curves fitted to the cumulative concentration-
response data by nonlinear regression using the formula y
= A + (B - A)/[1 + (10C/10X)D], where A = bottom plateau,
B = top plateau, C = log(IC50), D = slope coefficient
(GraphPad Prism 3.0). Resting transmembrane potentials
(RMP), input resistance and spike threshold of neurons
from normal rats and from arthritic rats were compared
using an unpaired t-test. Drug effects on EPSC peak and
AUC, spike threshold, and mEPSC amplitude and fre-
quency were compared to predrug control values using
the paired t-test. mEPSCs frequency and amplitude distri-
butions were determined using the Mini Analysis Program
6.0.3 program (Synaptosoft Inc.). The Kolmogorov-Smir-
nov test was used for statistical analysis of the cumulative
distribution of mEPSC amplitude and frequency.
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